Description and Brand Names
Información sobre medicamentos proporcionada por: IBM Micromedex
US Brand Name
Midostaurin is used in combination with standard cytarabine and daunorubicin induction and cytarabine consolidation chemotherapy to treat adults with newly diagnosed acute myeloid leukemia (AML) that is FLT3 mutation-positive.
This medicine is also used to treat aggressive systemic mastocytosis (ASM), systemic mastocytosis with associated hematological neoplasm (SM-AHN), or mast cell leukemia (MCL).
This medicine is available only with your doctor's prescription.
This product is available in the following dosage forms: